Drug Profile
AMG 747
Alternative Names: AMG747Latest Information Update: 01 May 2014
Price :
$50
*
At a glance
- Originator Amgen
- Class Acetic acids; Antipsychotics; Fluorobenzenes; Piperazines; Small molecules
- Mechanism of Action Glycine transporter 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 17 Feb 2014 Discontinued - Phase-II for Schizophrenia in Australia, Canada, Czech Republic, France, Malaysia, New Zealand, Poland, Russia, Singapore, Spain, United Kingdom and USA (PO) prior to February 2014
- 14 Jun 2013 Amgen terminates two phase II trials in Schizoprenia in the USA, Australia, Canada, Czech Republic, France, Malaysia, New Zealand, Poland, Russian, Singapore, Spain and the United Kingdom (NCT01568229; NCT01568216)
- 09 May 2013 Phase-II clinical trials in Schizophrenia in United Kingdom, Singapore, Malaysia, Russia, Poland, Spain, France, Czech Republic (PO)